Preventing cancer metastasis by new therapeutic targets: Decoding the tumor microenvironment

The field of oncology research is increasingly focusing on understanding the tumor microenvironment (TME), particularly its implications for drug resistance, cancer metastasis and the development of novel therapeutic strategies. Researchers recognize that the TME is not merely a structural scaffold for cancer cells, but a dynamic and active participant in tumor progression. By continuously altering signaling pathways, the TME contributes to therapeutic resistance and promotes metastatic potential, making it a critical focus for translational cancer research.

Despite significant advancements in fundamental research on tumor metastasis, effectively translating this understanding particularly the influence of the tumor microenvironment, interactions with stromal components, and potential therapeutic manipulation into clinical applications remains a considerable challenge. Groundbreaking studies have begun to uncover these intricate interactions, yet significant knowledge gap persists, particularly in fully characterizing the diverse cell populations within the microenvironment, understanding their collective impact on tumor behavior, organ-specific metastasis, and the exploration of targeted therapies.

This Research Topic aims to delve deeper into these unresolved questions, focusing on elucidating the complex dynamics of the tumor microenvironment and its role in cancer metastasis and drug resistance. The goal is to identify novel therapeutic targets that can halt or even reverse cancer progression by modulating the tumor microenvironment. The exploration involves targeting distinct pathways using small molecules, ligands, and inhibitors that may serve as potential therapeutic intervention points. Reprogramming the tumor immune microenvironment through tumor-specific delivery systems may enhance the efficacy of synergistic immunotherapeutic combinations while minimizing the side effects. By addressing these knowledge gaps, this research aims to establish a more robust framework for developing targeted therapies and improving clinical outcomes for cancer patients.

To gather further insights into the complex landscape of the tumor microenvironment, we welcome articles addressing, but not limited to, the following themes:

o The role of immune cells in the tumor microenvironment

o Interactions between cancer cells and the extracellular matrix

o Mechanisms of resistance to current therapies within the microenvironment

o Impact of the tumor microenvironment on metastasis progression

o Development of innovative strategies to modulate the tumor microenvironment for therapeutic benefit

o Identification of pharmacological targets within the tumor microenvironment

o Drug delivery systems targeting the tumor microenvironment

o Pharmacokinetics, pharmacodynamics, and safety of novel anticancer agents modulating the tumor microenvironment

o Novel therapeutic strategies for remodeling the tumor microenvironment

We invite original research articles, comprehensive reviews, and cutting-edge methodologies that contribute to a more profound understanding of the tumor microenvironment and its potential in revolutionizing cancer therapy.